Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

tablets

tablets is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 8
Pipeline programs 746
News articles 0
Drug details — tablets
Class
—
Route
—
Patents
8
Programs
746
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

tablets is an FDA-listed pharmaceutical active ingredient.

Key facts

INN tablets

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 042011 Phase 3 · George Institute for · Langerhans Cell Histiocytosis
  2. 1245-0256 Phase 3 · Boehringer Ingelheim · Chronic kidney disease in paediatric patients
  3. 1378-0041 Phase 3 · Boehringer Ingelheim · Type 2 diabetes, hypertension, cardiovascular disease
  4. 156-201-00307 Phase 3 · Otsuka Beijing Research · Autosomal Recessive Polycystic Kidney Disease
  5. 1821-FSH-301 Phase 3 · Fulcrum Therapeutics · Facioscapulohumeral Muscular Dystrophy (FSHD)
  6. 19920 Phase 3 · Bayer · Proteinuria, Chronic kidney disease
  7. 20190009 Phase 3 · Amgen · Previously treated locally advanced and unresectable or meta
  8. 20190172 Phase 3 · Amgen · Colorectal Cancer (CRC)

Related patents

Browse patents

  1. US 9901546

    Orally disintegrable tablets

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8372812

    Phospholipid and protein tablets

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7875292

    Orally disintegrable tablets

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7431942

    Orally disintegrable tablets

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 6589507

    Foaming antacid suspension tablets

    Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6328994

    Orally disintegrable tablets

    Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6306444

    Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same

    Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6117430

    Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same

    Expires Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is tablets?

tablets is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.